Olema Pharmaceuticals, Inc. (OLMA) Tops Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts OLMA Hot Sheet
Join SI Premium – FREE
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q4 EPS of ($0.51), $0.13 better than the analyst estimate of ($0.64).
For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance
- CrowdStrike posts record ARR growth, raises full-year outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
